A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...
Toshiba has overcome this challenge by developing a third‑generation simulated bifurcation (SB) algorithm. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results